Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 7, 2007 - Issue 8
Submit an article Journal homepage
141
Views
8
CrossRef citations to date
0
Altmetric
Review

Novel candidate disease for gene therapy: metachromatic leukodystrophy

Alessandra Biffi San Raffaele Telethon Institute for Gene Therapy and Vita Salute University, H. San Raffaele Scientific Institute, Milan, Italy +39 02 26434678; +39 02 26434668; a.biffi @hsr.it
&
Luigi Naldini San Raffaele Telethon Institute for Gene Therapy and Vita Salute University, H. San Raffaele Scientific Institute, Milan, Italy +39 02 26434678; +39 02 26434668; a.biffi @hsr.it
Pages 1193-1205 | Published online: 14 Aug 2007

Bibliography

  • NEUFELD EF: Lysosomal disease. Ann. Rev. Biochem. (1991) 60:257-280.
  • AICARDÌ J: Disease of the Nervous System in Childhood. Cambridge University Press, UK (1998).
  • NEUFELD EF, MUENZER J: The Metabolic and Molecular Bases of Inherited Disease. Scriver CR, Beaudet AL, Sly WS, Valle D (Eds), McGraw-Hill, New York, USA (2001).
  • COSMA MP, PEPE S, ANNUNZIATA I et al.: The multiple sulfatase deficiency gene encodes an essential and limiting factor for the activity of sulfatases. Cell (2003) 113:445-456.
  • DIERKS T, SCHMIDT B, BORISSENKO LV et al.: Multiple sulfatase deficiency is caused by mutations in the gene encoding the human C(α)-formylglycine generating enzyme. Cell (2003) 113:435-444.
  • ENG B, NAKAMURA LN, O'REILLY N et al.: Identification of nine novel arylsulfatase a (ARSA) gene mutations in patients with metachromatic leukodystrophy (MLD). Hum. Mutat. (2003) 22:418-419.
  • BERNA L, GIESELMANN V, POUPETOVA H, HREBICEK M, ELLEDER M, LEDVINOVA J: Novel mutations associated with metachromatic leukodystrophy: phenotype and expression studies in nine Czech and Slovak patients. Am. J. Med. Genet. (2004) 129A:277-281.
  • MARCAO AM, WIEST R, SCHINDLER K et al.: Adult onset metachromatic leukodystrophy without electroclinical peripheral nervous system involvement: a new mutation in the ARSA gene. Arch. Neurol. (2005) 62:309-313.
  • LUGOWSKA A, AMARAL O, BERGER J et al.: Mutations c.459+1G > A and p.P426L in the ARSA gene: prevalence in metachromatic leukodystrophy patients from European countries. Mol. Genet. Metab. (2005) 86:353-359.
  • VON FIGURA K, JAEKEN J: Metachromatic leukodystrophy. In: The Metabolic and Molecular Bases of Inherited Diseases (Volume 3, 8th Edition). Scriver CR, Beaudet AL, Valle D, Sly WS (Eds), McGraw-Hill, UK (2001):3695-3724.
  • RAUSCHKA H, COLSCH B, BAUMANN N et al.: Late-onset metachromatic leukodystrophy: genotype strongly influences phenotype. Neurology (2006) 67:859-863.
  • SEVIN C, AUBOURG P, CARTIER N: Enzyme, cell and gene-based therapies for metachromatic leukodystrophy. J. Inherit. Metab. Dis. (2007) 30:175-183.
  • HESS B, SAFTIG P, HARTMANN D et al.: Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy. Proc. Natl. Acad. Sci. USA (1996) 93:14821-14826.
  • OHMI K, GREENBERG DS, RAJAVEL KS, RYAZANTSEV S, LI HH, NEUFELD EF: Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB. Proc. Natl. Acad. Sci. USA (2003) 100:1902-1907.
  • YAGHOOTFAM A, GIESELMANN V, ECKHARDT M: Delay of myelin formation in arylsulphatase A-deficient mice. Eur. J. Neurosci. (2005) 21:711-720.
  • BARRANGER JA, O'ROURKE E: Lessons learned from the development of enzyme therapy for Gaucher disease. J. Inherit. Metab. Dis. (2001) 24:89-96.
  • DESNICK RJ, IOANNOU YA, ENG CM: In: Metabolic and Molecular Bases of Inherited Diseases. Scriver CR, Beaudet AL, Sly WS, Valle D (Eds), McGraw-Hill, UK (2001):3733-3774.
  • ENG CM, GUFFON N, WILCOX WR et al.: Safety and efficacy of recombinant human α-galactosidase A replacement therapy in Fabry's disease. N. Engl. J. Med. (2001) 345:9-16.
  • KAKKIS ED, MUENZER J, TILLER GE et al.: Enzyme-replacement therapy in mucopolysaccharidosis I. N. Engl. J. Med. (2001) 344:182-188.
  • BRADY RO, SCHIFFMANN R: Enzyme-replacement therapy for metabolic storage disorders. Lancet Neurol. (2004) 3:752-756.
  • MATZNER UH: Enzyme replacement improves nervous system pathology and function in a mouse model for metachromatic leukodystrophy. Hum. Mol. Genet. (2005) 14:1139-1152.
  • VAN DEN HOUT JM, KAMPHOVEN JH, WINKEL LP et al.: Long-term intravenous treatment of Pompe disease with recombinant human α-glucosidase from milk. Pediatrics (2004) 113:448-457.
  • KAKKIS E, LESTER T, YANG R et al.: Successful induction of immune tolerance to enzyme replacement therapy in canine mucopolysaccharidosis I. Proc. Natl. Acad. Sci. USA (2004) 101:829-834.
  • MIEBACH E: Enzyme replacement therapy in mucopolysaccharidosis Type I. Acta Paediatr. Suppl. (2005) 94:58-60.
  • KRIVIT W, PETERS C, SHAPIRO EG: Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease Type III. Curr. Opin. Neurol. (1999) 12:167-176.
  • KRIVIT W, SUNG JH, SHAPIRO EG, LOCKMAN LA: Microglia: the effector cell for reconstitution of the central nervous system following bone marrow transplantation for lysosomal and peroxisomal storage diseases. Cell Transplant. (1995) 4:385-392.
  • ESCOLAR ML, POE MD, PROVENZALE JM et al.: Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N. Engl. J. Med. (2005) 352:2069-2081.
  • PETERS C, STEWARD CG: Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines. Bone Marrow Transplant. (2003) 31:229-239.
  • BREDIUS RG, LAAN LA, LANKESTER AC et al.: Early marrow transplantation in a pre-symptomatic neonate with late infantile metachromatic leukodystrophy does not halt disease progression. Bone Marrow Transplant. (2007) 39:309-310.
  • KAY MA, GLORIOSO JC, NALDINI L: Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat. Med. (2001) 7:33-40.
  • GLORIOSO JC, MATA M, FINK DJ: Therapeutic gene transfer to the nervous system using viral vectors. J. Neurovirol. (2003) 9:165-172.
  • SONDHI D, HACKETT NR, PETERSON DA et al.: Enhanced survival of the LINCL mouse following CLN2 gene transfer using the rh.10 rhesus macaque-derived adeno-associated virus vector. Mol. Ther. (2007) 15:481-491.
  • CONSIGLIO A, QUATTRINI A, MARTINO S et al.: In vivo gene therapy of metachromatic leukodystrophy by lentiviral vectors: correction of neuropathology and protection against learning impairment in affected mice. Nat. Med. (2001) 7:310-316.
  • BOSCH A, PERRET E, DESMARIS N, TRONO D, HEARD JM: Reversal of pathology in the entire brain of mucopolysaccharidosis type VII mice after lentivirus-mediated gene transfer. Hum. Gene Ther. (2000) 11:1139-1150.
  • STEIN CS, GHODSI A, DERKSEN T, DAVIDSON BL: Systemic and central nervous system correction of lysosomal storage in mucopolysaccharidosis type VII mice. J. Virol. (1999) 73:3424-3429.
  • STEIN CS, KANG Y, SAUTER SL et al.: In vivo treatment of hemophilia A and mucopolysaccharidosis type VII using nonprimate lentiviral vectors. Mol. Ther. (2001) 3:850-856.
  • SKORUPA AF, FISHER JK, WILSON JM, PARENTE MK, WOLFE JH: Sustained production of beta-glucuronidase from localized sites after AAV vector gene transfer results in widespread distribution of enzyme and reversal of lysosomal storage lesions in a large volume of brain in mucopolysaccharidosis VII mice. Exp. Neurol. (1999) 160:17-27.
  • DESMARIS N, VEROT L, PUECH JP, CAILLAUD C, VANIER MT, HEARDT JM: Prevention of neuropathology in the mouse model of Hurler syndrome. Ann. Neurol. (2004) 56:68-76.
  • CIRON C, DESMARIS N, COLLE MA et al.: Gene therapy of the brain in the dog model of Hurler's syndrome. Ann. Neurol. (2006) 60:204-213.
  • CRESSANT A, DESMARIS N, VEROT L et al.: Improved behavior and neuropathology in the mouse model of Sanfilippo Type IIIB disease after adeno-associated virus-mediated gene transfer in the striatum. J. Neurosci. (2004) 24:10229-10239.
  • SEVIN C, BENRAISS A, VAN DAM D et al.: Intracerebral adeno-associated virus-mediated gene transfer in rapidly progressive forms of metachromatic leukodystrophy. Hum. Mol. Genet. (2006) 15:53-64.
  • SEVIN C, VEROT L, BENRAISS A et al.: Partial cure of established disease in an animal model of metachromatic leukodystrophy after intracerebral adeno-associated virus-mediated gene transfer. Gene Ther. (2007) 14:405-414.
  • NALDINI L, BLOMER U, GALLAY P et al.: In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science (1996) 272:263-267.
  • BLOMER U, NALDINI L, KAFRI T, TRONO D, VERMA IM, GAGE FH: Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J. Virol. (1997) 71:6641-6649.
  • ZUFFEREY R, NAGY D, MANDEL RJ, NALDINI L, TRONO D: Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. (1997) 15:871-875.
  • ZUFFEREY R, DULL T, MANDEL RJ et al.: Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. (1998) 72:9873-9880.
  • KORDOWER JH, BLOCH J, MA SY et al.: Lentiviral gene transfer to the nonhuman primate brain. Exp. Neurol. (1999) 160:1-16.
  • LUCA T, GIVOGRI MI, PERANI L et al.: Axons mediate the distribution of arylsulfatase a within the mouse hippocampus upon gene delivery. Mol. Ther. (2005) 12:669-679.
  • HASKELL RE, HUGHES SM, CHIORINI JA, ALISKY JM, DAVIDSON BL: Viral-mediated delivery of the late-infantile neuronal ceroid lipofuscinosis gene, TPP-I to the mouse central nervous system. Gene Ther. (2003) 10:34-42.
  • GRIFFEY M, BIBLE E, VOGLER C et al.: Adeno-associated virus 2-mediated gene therapy decreases autofluorescent storage material and increases brain mass in a murine model of infantile neuronal ceroid lipofuscinosis. Neurobiol. Dis. (2004) 16:360-369.
  • BROOKS AI, STEIN CS, HUGHES SM et al.: Functional correction of established central nervous system deficits in an animal model of lysosomal storage disease with feline immunodeficiency virus-based vectors. Proc. Natl. Acad. Sci. USA (2002) 99:6216-6221.
  • KURAI T, HISAYASU S, KITAGAWA R et al.: AAV1 Mediated co-expression of formylglycine-generating enzyme and arylsulfatase A efficiently corrects sulfatide storage in a mouse model of metachromatic leukodystrophy. Mol. Ther. (2007) 15:38-43.
  • FRALDI A, BIFFI A, LOMBARDI A et al.: SUMF1 enhances sulfatase activities in vivo in five sulfatase deficiencies. Biochem. J. (2007) 403(2):305-312.
  • WATSON GL, SAYLES JN, CHEN C et al.: Treatment of lysosomal storage disease in MPS VII mice using a recombinant adeno-associated virus. Gene Ther. (1998) 5:1642-1649.
  • PRILLER J, FLUGEL A, WEHNER T et al.: Targeting gene-modified hematopoietic cells to central nervous system; use of green fluorescent proteine uncovers microglial engraftment. Nat. Med. (2001) 7:1356-1361.
  • BIFFI A, CAPOTONDO A, FASANO S et al.: Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in mice. J. Clin. Invest. (2006) 116:3070-3082.
  • LEIMING T, MANN L, DEL PILAR MARTIN M et al.: Functional amelioration of murine galactosialidosis by genetically modified bone marrow hematopoietic progenitor cells. Blood (2002) 99:3169-3178.
  • ZHENG Y, ROZENGURT N, RYAZANTSEV S, KOHN DB, SATYAKE N, NEUFELD EF: Treatment of the mouse model of mucopolysaccharidosis I with retrovirally tyransduced bone marrow. Mol. Genet. Metab. (2003) 79:233-244.
  • WADA R, TIFFT CJ, PROIA RL: Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation. Proc. Natl. Acad. Sci. USA (2000) 97:10954-10959.
  • GERMAN DC, LIANG CL, SONG T, YAZDANI U, XIE C, DIETSCHY JM: Neurodegeneration in the Niemann-Pick C mouse: glial involvement. Neuroscience (2002) 109:437-450.
  • EGLITIS MA, MEZEY E: Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc. Natl. Acad. Sci. USA (1997) 94:4080-4085.
  • KENNEDY DW, ABKOWITZ JL: Kinetics of central nervous system microglial and macrophage engraftment. Analysis using a transgenic bone marrow transplantation model. Blood (1997) 90:986-993.
  • BIFFI A, DE PALMA M, QUATTRINI A et al.: Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells. J. Clin. Invest. (2004) 113:1118-1129.
  • YEAGER AM, SHINOHARA M, SHINN C: Hematopoietic cell transplantation after administration of high-dose busulfan in murine globoid cell leukodystrophy (the twitcher mouse). Pediatr. Res. (1991) 29:302-305.
  • YEAGER AM, SHINN C, SHINOHARA M, PARDOLL DM: Hematopoietic cell transplantation in the twitcher mouse. The effects of pretransplant conditioning with graded doses of busulfan. Transplantation (1993) 56:185-190.
  • SANO R, TESSITORE A, INGRASSIA A, D'AZZO A: Chemokine-induced recruitment of genetically modified bone marrow cells into the CNS of GM1-gangliosidosis mice corrects neuronal pathology. Blood (2005) 106:2259-2268.
  • HOFLING AA, DEVINE S, VOGLER C, SANDS MS: Human CD34+ hematopoietic progenitor cell-directed lentiviral-mediated gene therapy in a xenotransplantation model of lysosomal storage disease. Mol. Ther. (2004) 9:856-865.
  • ASHEUER M, PFLUMIO F, BENHAMIDA S et al.: Human CD34+ cells differentiate into microglia and express recombinant therapeutic protein. Proc. Natl. Acad. Sci. USA (2004) 101:3557-3562.
  • MATZNER U, HARZER K, LEARISH RD, BARRANGER JA, GIESELMANN V: Long-term expression and transfer of arylsulfatase A into brain of arylsulfatase A-deficient mice transplanted with bone marrow expressing the arylsulfatase A cDNA from a retroviral vector. Gene Ther. (2000) 7:1250-1257.
  • MATZNER U, SCHESTAG F, HARTMANN D et al.: Bone marrow stem cell gene therapy of arylsulfatase A-deficient mice, using an arylsulfatase A mutant that is hypersecreted from retrovirally transduced donor-type cells. Hum. Gene Ther. (2001) 12:1021-1033.
  • MIYOSHI H, SMITH KA, MOSIER DE, VERMA IM, TORBETT BE: Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science (1999) 283:682-686.
  • GUENECHEA G, GAN OI, INAMITSU T et al.: Transduction of human CD34+ CD38- bone marrow and cord blood-derived SCID-repopulating cells with third-generation lentiviral vectors. Mol. Ther. (2000) 1:566-573.
  • GUENECHEA G, GAN OI, DORRELL C, DICK JE: Distinct classes of human stem cells that differ in proliferative and self-renewal potential. Nat. Immunol. (2001) 2:75-82.
  • AILLES L, SCHMIDT M, SANTONI DE SIO FR et al.: Molecular evidence of lentiviral vector-mediated gene transfer into human self-renewing, multi-potent, long-term NOD/SCID repopulating hematopoietic cell. Mol. Ther. (2002) 6:615-626.
  • OUREDNIK V, OUREDNIK J, FLAX JD et al.: Segregation of human neural stem cells in the developing primate forebrain. Science (2001) 293:1820-1824.
  • TAMAKI S, ECKERT K, HE D et al.: Engraftment of sorted/expanded human central nervous system stem cells from fetal brain. J. Neurosci. Res. (2002) 69:976-986.
  • FRICKER RA, CARPENTER MK, WINKLER C, GRECO C, GATES MA, BJORKLUND A: Site-specific migration and neuronal differentiation of human neural progenitor cells after transplantation in the adult rat brain. J. Neurosci. (1999) 19:5990-6005.
  • RUBIO FJ, BUENO C, VILLA A, NAVARRO B, MARTINEZ-SERRANO A: Genetically perpetuated human neural stem cells engraft and differentiate into the adult mammalian brain. Mol. Cell Neurosci. (2000) 16:1-13.
  • ENGLUND U, BJORKLUND A, WICTORIN K: Migration patterns and phenotypic differentiation of long-term expanded human neural progenitor cells after transplantation into the adult rat brain. Brain Res. Dev. Brain Res. (2002) 134:123-141.
  • WU P, TARASENKO YI, GU Y, HUANG LY, COGGESHALL RE, YU Y: Region-specific generation of cholinergic neurons from fetal human neural stem cells grafted in adult rat. Nat. Neurosci. (2002) 5:1271-1278.
  • FLAX JD, AURORA S, YANG C et al.: Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. Nat. Biotechnol. (1998) 16:1033-1039.
  • GAGE FH, RAY J, FISHER LJ: Isolation, characterization, and use of stem cells from the CNS. Ann. Rev. Neurosci. (1995) 18:159-192.
  • MCKAY R: Stem cells in the central nervous system. Science (1997) 276:66-71.
  • SNYDER EY: Immortalized neural stem cells: insights into development; prospects for gene therapy and repair. Proc. Natl. Acad. Sci. USA (1995) 107:195-204.
  • SNYDER EY, TAYLOR RM, WOLFE JH: Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Nature (1995) 374:367-370.
  • LEE JP, JEYAKUMAR M, GONZALEZ R et al.: Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease. Nat. Med. (2007) 13(4):439-447.
  • BUCHET D, SERGUERA C, ZENNOU V, CHARNEAU P, MALLET J: Long-term expression of β-glucuronidase by genetically modified human neural progenitor cells grafted into the mouse central nervous system. Mol. Cell Neurosci. (2002) 19:389-401.
  • MENG XL, SHEN JS, OHASHI T, MAEDA H, KIM SU, ETO Y: Brain transplantation of genetically engineered human neural stem cells globally corrects brain lesions in the mucopolysaccharidosis Type VII mouse. J. Neurosci. Res. (2003) 74:266-277.
  • TAYLOR RM, WOLFE JH: Decreased lysosomal storage in the adult MPS VII mouse brain in the vicinity of grafts of retroviral vector-corrected fibroblasts secreting high levels of β-glucuronidase. Nat. Med. (1997) 3:771-774.
  • ROSS CJ, RALPH M, CHANG PL: Somatic gene therapy for a neurodegenerative disease using microencapsulated recombinant cells. Exp. Neurol. (2000) 166:276-286.
  • BARSOUM SC, MILGRAM W, MACKAY W et al.: Delivery of recombinant gene product to canine brain with the use of microencapsulation. J. Lab. Clin. Med. (2003) 142:399-413.
  • KOSUGA M, TAKAHASHI S, TANABE A et al.: Widespread distribution of adenovirus-transduced monkey amniotic epithelial cells after local intracerebral injection: implication for cell-mediated therapy for lysosome storage disorders. Cell Transplant. (2001) 10:435-439.
  • PLUCHINO S, QUATTRINI A, BRAMBILLA E et al.: Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature (2003) 422:688-694.
  • PLUCHINO S, ZANOTTI L, ROSSI B et al.: Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature (2005) 436:266-271.
  • KAWABATA K, MIGITA M, MOCHIZUKI H et al.: Ex vivo cell-mediated gene therapy for metachromatic leukodystrophy using neurospheres. Brain Res. (2006) 1094:13-23.
  • BLAKEMORE WF, GILSON JM, CRANG AJ: The presence of astrocytes in areas of demyelination influences remyelination following transplantation of oligodendrocyte progenitors. Exp. Neurol. (2003) 184:955-963.
  • KIM JH, AUERBACH JM, RODRIGUEZ-GOMEZ JA et al.: Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature (2002) 418:50-56.
  • GIVOGRI MI, GALBIATI F, FASANO S et al.: Oligodendroglial progenitor cell therapy limits central neurological deficits in mice with metachromatic leukodystrophy. J. Neurosci. (2006) 26:3109-3119.
  • KLEIN D, SCHMANDT T, MUTH-KOHNE E et al.: Embryonic stem cell-based reduction of central nervous system sulfatide storage in an animal model of metachromatic leukodystrophy. Gene Ther. (2006) 13:1686-1695.
  • SARDIELLO M, ANNUNZIATA I, ROMA G, BALLABIO A: Sulfatases and sulfatase modifying factors: an exclusive and promiscuous relationship. Hum. Mol. Genet. (2005) 14:3203-3217.
  • FISCHER A, ABINA SH, THRASHER A, VON KALLE C, CAVAZZANA-CALVO M: LMO2 and gene therapy for severe combined immunodeficiency. N. Engl. J. Med. (2004) 350:2526-2527.
  • DE PALMA M, MONTINI E, SANTONI DE SIO FR et al.: Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells. Blood (2005) 105:2307-2315.
  • MONTINI E, CESANA D, SCHMIDT M et al.: Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat. Biotechnol. (2006) 24:687-696.
  • UNGER ER, SUNG JH, MANIVEL JC, CHENGGIS ML, BLAZAR BR, KRIVIT W: Male donor-derived cells in the brains of female sex-mismatched bone marrow transplant recipients: a Y-chromosome specific in situ hybridization study. J. Neuropathol. Exp. Neurol. (1993) 52:460-470.
  • VITE CH, MCGOWAN JC, NIOGI SN et al.: Effective gene therapy for an inherited CNS disease in a large animal model. Ann. Neurol. (2005) 57:355-364.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.